PuraPharm Corporation Limited
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through fi…
Drug Manufacturers - Specialty & Generic
HK, Tai Po [HQ]
1498.HK/Financial Reporting
Income Statements
11 Sheets · Starting from 2013In Million HKD. Margins, Growth Rates In %
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 342.00 | 366.00 | 473.00 | 535.00 | 591.00 | 745.00 | 695.00 | 601.00 | 659.00 | 448.00 | 406.00 | |
|
EPS
|
- - | 74.54 | 0.15 | 0.14 | 0.01 | 0.08 | -0.82 | 0.09 | -0.31 | -0.30 | -0.27 | |
| Diluted in mil. | - - | 74.54 | 0.15 | 0.14 | 0.01 | 0.08 | -0.82 | 0.09 | -0.31 | -0.30 | -0.27 | |
|
Profit
|
219.00 | 232.00 | 305.00 | 348.00 | 395.00 | 454.00 | 397.00 | 368.00 | 421.00 | 260.00 | 214.00 | |
| Gross Margin | 64.04 | 63.36 | 64.51 | 65.08 | 66.92 | 61.02 | 57.13 | 61.26 | 63.96 | 58.16 | 52.81 | |
| Pre Tax | 29.00 | 42.00 | 40.00 | 38.00 | 10.00 | 26.00 | -216.00 | 40.00 | -117.00 | -119.00 | -102.00 | |
| Profit Margin | 8.67 | 11.55 | 8.47 | 7.21 | 1.75 | 3.56 | -31.06 | 6.68 | -17.77 | -26.60 | -25.11 | |
| ETR | 11.45 | 18.48 | 29.09 | 16.82 | 81.72 | 21.58 | -5.14 | 21.15 | -4.00 | -0.87 | -3.69 | |
| Net | 26.00 | 34.00 | 28.00 | 32.00 | 1.00 | 20.00 | -227.00 | 31.00 | -121.00 | -120.00 | -106.00 | |
| Profit Margin | 7.67 | 9.41 | 6.01 | 6.00 | 0.32 | 2.79 | -32.66 | 5.27 | -18.48 | -26.83 | -26.07 | |
| EBITDA | 49.00 | 65.00 | 59.00 | 55.00 | 21.00 | 44.00 | 5.00 | 42.00 | 67.00 | -15.00 | -2.00 | |
| EBITDA Margin | 14.42 | 17.80 | 12.48 | 10.39 | 3.70 | 6.01 | 0.79 | 7.10 | 10.27 | -3.53 | -0.74 | |
| Operating Income | 37.00 | 51.00 | 46.00 | 40.00 | -2.00 | 9.00 | -61.00 | -4.00 | 17.00 | -64.00 | -51.00 | |
| Operating Margin | 10.97 | 14.17 | 9.74 | 7.54 | -0.49 | 1.24 | -8.80 | -0.81 | 2.67 | -14.40 | -12.68 | |
| Interest Income | 12.00 | 12.00 | 9.00 | 8.00 | 16.00 | 21.00 | - - | - - | - - | - - | - - | |
| Loss | -299.00 | -311.00 | -424.00 | -488.00 | -564.00 | -697.00 | -757.00 | -606.00 | -641.00 | -512.00 | -458.00 | |
| Cost of Revenue | -123.00 | -134.00 | -168.00 | -187.00 | -195.00 | -290.00 | -298.00 | -233.00 | -237.00 | -187.00 | -192.00 | |
|
Operating Expenses
|
-176.00 | -177.00 | -256.00 | -301.00 | -369.00 | -406.00 | -458.00 | -373.00 | -404.00 | -325.00 | -266.00 | |
| R&D | -16.00 | -16.00 | -15.00 | -18.00 | -19.00 | -26.00 | -33.00 | -20.00 | -23.00 | -20.00 | -14.00 | |
| G&A | -74.00 | -72.00 | -106.00 | -130.00 | -173.00 | -174.00 | -224.00 | -152.00 | -168.00 | -157.00 | -171.00 | |
| SG&A | -181.00 | -180.00 | -259.00 | -308.00 | -398.00 | -447.00 | -425.00 | -352.00 | -380.00 | -303.00 | -249.00 | |
| S&M | -101.00 | -99.00 | -140.00 | -154.00 | -191.00 | -229.00 | -226.00 | -210.00 | -220.00 | -157.00 | -91.00 | |
| Depreciation and Amortization | -11.00 | -13.00 | -13.00 | -15.00 | -24.00 | -35.00 | -66.00 | -47.00 | -50.00 | -48.00 | -48.00 | |
| Interest Expenses | - - | -13.00 | -10.00 | -9.00 | -18.00 | -24.00 | -31.00 | -30.00 | -27.00 | -24.00 | -27.00 | |
| Other Expenses | -7.00 | -9.00 | -6.00 | -1.00 | -13.00 | -17.00 | -154.00 | -45.00 | -134.00 | -54.00 | -50.00 | |
|
WA Shares Outstanding
|
- - | - - | 195.00 | 223.00 | 239.00 | 246.00 | 276.00 | 370.00 | 393.00 | 394.00 | 395.00 | |
| Diluted | - - | - - | 195.00 | 223.00 | 239.00 | 246.00 | 276.00 | 371.00 | 393.00 | 394.00 | 395.00 |